Insider Selling: Avantor, Inc. (NYSE:AVTR) CAO Sells 4,907 Shares of Stock

Avantor, Inc. (NYSE:AVTR) CAO Steven W. Eck sold 4,907 shares of the business’s stock in a transaction that occurred on Wednesday, February 26th. The stock was sold at an average price of $17.53, for a total value of $86,019.71. Following the sale, the chief accounting officer now owns 40,604 shares of the company’s stock, valued at $711,788.12. The trade was a 10.78 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website.

Avantor Stock Performance

NYSE AVTR opened at $16.71 on Friday. The stock has a market cap of $11.37 billion, a PE ratio of 16.06, a P/E/G ratio of 1.55 and a beta of 1.28. The company has a current ratio of 1.07, a quick ratio of 0.70 and a debt-to-equity ratio of 0.54. Avantor, Inc. has a twelve month low of $16.41 and a twelve month high of $28.00. The stock has a fifty day simple moving average of $20.51 and a 200-day simple moving average of $22.69.

Avantor (NYSE:AVTR) last released its quarterly earnings results on Wednesday, February 12th. The company reported $0.27 earnings per share for the quarter, topping analysts’ consensus estimates of $0.26 by $0.01. Avantor had a return on equity of 12.17% and a net margin of 10.49%. During the same quarter in the previous year, the firm posted $0.22 earnings per share. Equities analysts anticipate that Avantor, Inc. will post 1.06 earnings per share for the current year.

Hedge Funds Weigh In On Avantor

A number of hedge funds have recently modified their holdings of the business. MassMutual Private Wealth & Trust FSB lifted its stake in Avantor by 99.5% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,253 shares of the company’s stock worth $26,000 after acquiring an additional 625 shares in the last quarter. Smartleaf Asset Management LLC lifted its stake in Avantor by 106.3% during the 4th quarter. Smartleaf Asset Management LLC now owns 1,611 shares of the company’s stock worth $34,000 after acquiring an additional 830 shares in the last quarter. Nisa Investment Advisors LLC lifted its stake in Avantor by 69.6% during the 3rd quarter. Nisa Investment Advisors LLC now owns 2,035 shares of the company’s stock worth $53,000 after acquiring an additional 835 shares in the last quarter. Global Retirement Partners LLC lifted its stake in Avantor by 76.7% during the 4th quarter. Global Retirement Partners LLC now owns 2,459 shares of the company’s stock worth $52,000 after acquiring an additional 1,067 shares in the last quarter. Finally, UMB Bank n.a. lifted its stake in Avantor by 56.3% during the 4th quarter. UMB Bank n.a. now owns 2,981 shares of the company’s stock worth $63,000 after acquiring an additional 1,074 shares in the last quarter. 95.08% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several analysts recently commented on AVTR shares. Royal Bank of Canada dropped their price target on Avantor from $33.00 to $31.00 and set an “outperform” rating for the company in a research report on Monday, February 10th. Stifel Nicolaus dropped their target price on Avantor from $28.00 to $26.00 and set a “buy” rating for the company in a report on Monday, February 10th. UBS Group restated a “neutral” rating and issued a $25.00 target price (down from $29.00) on shares of Avantor in a report on Friday, January 17th. Morgan Stanley dropped their target price on Avantor from $27.00 to $25.00 and set an “overweight” rating for the company in a report on Monday, February 10th. Finally, Barclays dropped their target price on Avantor from $26.00 to $23.00 and set an “overweight” rating for the company in a report on Monday, February 10th. Three investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. Based on data from MarketBeat.com, Avantor presently has a consensus rating of “Moderate Buy” and a consensus target price of $25.92.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.